Relationship between cardiopulmonary bypass flow rate and cerebral embolization in dogs.
BACKGROUND
Cerebral embolization is a primary cause of cardiac surgical neurologic morbidity. During cardiopulmonary bypass (CPB), there are well-defined periods of embolic risk. In theory, cerebral embolization might be reduced by an increase in pump flow during these periods. The purpose of this study was to determine the CPB flow-embolization relation in a canine model.


METHODS
Twenty mongrel dogs underwent CPB at 35 degrees C with alpha-stat management and a fentanyl-midazolam anesthetic. In each animal, CPB flow was adjusted to achieve a mean arterial pressure of 65-75 mmHg. During CPB, an embolic load of 1.2 x 10(5) 67 microm fluorescent microspheres was injected into the arterial inflow line. Before and after embolization, cerebral blood flow was determined using 15-microm microspheres. Tissue was taken from 12 brain regions and microspheres were recovered. The relation between pump flow and embolization/g of brain was determined.


RESULTS
The mean arterial pressure at embolization was 67 +/-4 mmHg, and the range of pump flow was 0.9-3.5 l x min(-1)x m(-2). Cerebral blood flow was independent of pump flow. At lower pump flow, the percentage of that flow delivered to the brain increased. There was a strong inverse relation between pump flow and cerebral embolization (r = -0.708, P < 0.000 by Spearman rank order correlation).


CONCLUSIONS
Cerebral embolization is determined by the CPB flow. At an unchanged mean arterial pressure, as pump flow is reduced, a progressively greater proportion of that flow is delivered to the brain.
Sungurtekin
H
H
Department of Anesthesiology, Mayo Foundation and Mayo Clinic, Rochester, Minnesota 55905, USA.
Plöchl
W
W
Cook
D J
DJ
D000818:Animals; D001794:Blood Pressure / Q000502:physiology; D002315:Cardiopulmonary Bypass / Q000009:adverse effects*; D003326:Coronary Circulation / Q000502:physiology*; D004285:Dogs; D005456:Fluorescent Dyes; D020766:Intracranial Embolism / Q000209:etiology / Q000473:pathology / Q000503:physiopathology*; D008863:Microspheres; D018570:Risk Assessment
D005456:Fluorescent Dyes